none

Lung Cancer

Join Sanguine's Lung Cancer Patient Community to stay informed on upcoming trials
Join Sanguine's Lung Cancer Patient Community to stay informed on upcoming trials

We Bring Research To You

Lung cancer, the leading cause of cancer death in men and women in the United States, develops when there is an uncontrollable growth of abnormal cells in one or both lungs. Smoking causes the majority of lung cancers by damaging the cells that line the lungs. More than 500,000 people in the U.S. are living with lung cancer, and better medicine and treatment options are needed for lung cancer.

We believe patients like you are the key to making a difference in lung cancer research. Joining a research study can help advance the future of lung cancer research and impact the development of new treatments and cures.

Sanguine's unique model alleviates many of the difficulties associated with clinical trials and we make it easy for patients to contribute to research for medical conditions that matter most to them, regardless of their location or ability to travel. Sign up to learn more and participate today!

Sanguine's Expertise in Accelerating Psoriasis Research

25,000+
Members in
our community
3
Average # of times a
member has participated
500+
Studies completed
by Sanguine

We are currently recruiting for 2 Lung Cancer studies

STUDY NAME:

Lung Cancer At-Home Research Study

compensation:

$50

description

Volunteers with lung cancer are needed to participate in a research study from the comfort of their own home. The goal of this research is to develop new diagnostic and treatment options for patients living with lung cancer by analyzing biomarkers such as genetic, environmental, and microbial factors that may influence the disease's development.

location

United States

RECRUITMENT FOR THIS STUDY CLOSES IN:
THE STUDY IS NOW CLOSED
STUDY NAME:

Lung Cancer At-Home Research Study (MA only)

compensation:

description

Volunteers with lung cancer are needed to participate in a research study from the comfort of their own home in Massachusetts. The goal of this research is to develop new diagnostic and treatment options for patients living with lung cancer by analyzing biomarkers such as genetic, environmental, and microbial factors that may influence the disease's development.

location

Massachusetts

RECRUITMENT FOR THIS STUDY CLOSES IN:
THE STUDY IS NOW CLOSED

Nationwide Partners

We partner with these like-minded organizations and nonprofits to connect with Lupus patients who want to contribute and help accelerate research.

OUR PARTNERS INCLUDE:

Want to see more? View our full list of Nationwide Partners:

Join the Sanguine community!